JP2020533021A5 - - Google Patents

Download PDF

Info

Publication number
JP2020533021A5
JP2020533021A5 JP2020534820A JP2020534820A JP2020533021A5 JP 2020533021 A5 JP2020533021 A5 JP 2020533021A5 JP 2020534820 A JP2020534820 A JP 2020534820A JP 2020534820 A JP2020534820 A JP 2020534820A JP 2020533021 A5 JP2020533021 A5 JP 2020533021A5
Authority
JP
Japan
Prior art keywords
stem cells
gla
cells
delivery molecule
molecule according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020534820A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020533021A (ja
JP7365704B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2018/049618 external-priority patent/WO2019050997A1/en
Publication of JP2020533021A publication Critical patent/JP2020533021A/ja
Publication of JP2020533021A5 publication Critical patent/JP2020533021A5/ja
Application granted granted Critical
Publication of JP7365704B2 publication Critical patent/JP7365704B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020534820A 2017-09-05 2018-09-05 幹細胞へのペイロードの送達 Active JP7365704B2 (ja)

Applications Claiming Priority (13)

Application Number Priority Date Filing Date Title
US201762554533P 2017-09-05 2017-09-05
US201762554530P 2017-09-05 2017-09-05
US62/554,530 2017-09-05
US62/554,533 2017-09-05
US201762569411P 2017-10-06 2017-10-06
US201762569403P 2017-10-06 2017-10-06
US62/569,403 2017-10-06
US62/569,411 2017-10-06
US201762584565P 2017-11-10 2017-11-10
US62/584,565 2017-11-10
US201762593014P 2017-11-30 2017-11-30
US62/593,014 2017-11-30
PCT/US2018/049618 WO2019050997A1 (en) 2017-09-05 2018-09-05 LOAD DISTRIBUTION USEFUL IN STEM CELLS

Publications (3)

Publication Number Publication Date
JP2020533021A JP2020533021A (ja) 2020-11-19
JP2020533021A5 true JP2020533021A5 (cg-RX-API-DMAC7.html) 2021-10-14
JP7365704B2 JP7365704B2 (ja) 2023-10-20

Family

ID=63714024

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2020512854A Pending JP2020533976A (ja) 2017-09-05 2018-09-05 エキソソームを標的化する方法
JP2020534820A Active JP7365704B2 (ja) 2017-09-05 2018-09-05 幹細胞へのペイロードの送達
JP2020534821A Pending JP2020533404A (ja) 2017-09-05 2018-09-05 細胞内送達法
JP2024041903A Pending JP2024073589A (ja) 2017-09-05 2024-03-18 エキソソームを標的化する方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2020512854A Pending JP2020533976A (ja) 2017-09-05 2018-09-05 エキソソームを標的化する方法

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2020534821A Pending JP2020533404A (ja) 2017-09-05 2018-09-05 細胞内送達法
JP2024041903A Pending JP2024073589A (ja) 2017-09-05 2024-03-18 エキソソームを標的化する方法

Country Status (14)

Country Link
US (3) US20200407421A1 (cg-RX-API-DMAC7.html)
EP (3) EP3679127A1 (cg-RX-API-DMAC7.html)
JP (4) JP2020533976A (cg-RX-API-DMAC7.html)
KR (2) KR20200050961A (cg-RX-API-DMAC7.html)
CN (2) CN111065733A (cg-RX-API-DMAC7.html)
AU (2) AU2018330427A1 (cg-RX-API-DMAC7.html)
BR (2) BR112020004319A2 (cg-RX-API-DMAC7.html)
CA (2) CA3074291A1 (cg-RX-API-DMAC7.html)
IL (2) IL272908A (cg-RX-API-DMAC7.html)
MX (2) MX2020002442A (cg-RX-API-DMAC7.html)
PE (2) PE20201263A1 (cg-RX-API-DMAC7.html)
SG (2) SG11202001536PA (cg-RX-API-DMAC7.html)
WO (3) WO2019050998A1 (cg-RX-API-DMAC7.html)
ZA (2) ZA202000650B (cg-RX-API-DMAC7.html)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT3524618T (pt) 2013-03-15 2023-06-06 Gladiator Biosciences Inc Domínios gla como agentes de marcação
WO2019032628A1 (en) 2017-08-07 2019-02-14 The Regents Of The University Of California GENERATING PLATFORM FOR SAFE CELLULAR THERAPEUTIC AGENTS
JP2020533976A (ja) 2017-09-05 2020-11-26 グラディエーター バイオサイエンシーズ インコーポレイテッド エキソソームを標的化する方法
MY204234A (en) 2018-08-27 2024-08-16 Regeneron Pharma Use of raman spectroscopy in downstream purification
CN110036976B (zh) * 2019-05-08 2021-12-07 华南农业大学 一种阻断鸡禽白血病病毒垂直传播的方法及其应用
CN110423777A (zh) * 2019-07-23 2019-11-08 河南科技大学 无荧光染料标记外泌体及其制备方法
CN110711249B (zh) * 2019-09-19 2020-10-27 北京化工大学 一种溶酶体膜包覆纳米颗粒的制备方法
US20240066081A1 (en) * 2019-10-09 2024-02-29 Mayo Foundation For Medical Education And Research Canine distemper virus hemagglutinin and fusion polypeptides
KR102547446B1 (ko) * 2019-11-29 2023-06-26 서울대학교산학협력단 무표지 폴리다이아세틸렌 리포좀 기반의 엑소좀의 검출 방법
CN111803646B (zh) * 2020-06-04 2022-07-05 苏州大学 一种实体肿瘤联合治疗组合物
US12691076B2 (en) * 2020-06-23 2026-07-28 Board Of Regents, The University Of Texas System Methods and compositions related to extracellular vesicles
KR102659285B1 (ko) * 2020-08-11 2024-04-22 경북대학교 산학협력단 암세포 유래 엑소좀에 선택적으로 결합하는 펩타이드 및 이의 용도
CN112516110B (zh) * 2020-10-13 2022-05-13 北京化工大学 一种细胞膜包覆纳米酶的方法
CN112285195B (zh) * 2020-10-27 2021-08-10 江南大学 一种牛奶外泌体的特征性糖蛋白标志物和牛奶外泌体的特征性标志物分离方法
CN112553152B (zh) * 2020-10-27 2024-09-17 重庆市铂而斐细胞生物技术有限公司 一种快速提高脂肪间充质干细胞外泌体产量的方法
KR102285160B1 (ko) * 2020-12-24 2021-08-03 주식회사 타임바이오 전구세포에서 유래한 다기능성 엑소좀을 포함하는 피부염 예방 또는 치료용 약학적 조성물
CN115684590A (zh) * 2021-07-26 2023-02-03 上海交通大学医学院附属第九人民医院 一种检测细胞外囊泡内含物的装置、方法、存储介质、处理设备和检测试剂盒
KR102739746B1 (ko) * 2021-10-25 2024-12-10 인하대학교 산학협력단 바르토넬라 헨셀라이 유래 세포외 소포체를 이용한 바르토넬라 감염증 진단 방법
CN114940967B (zh) * 2022-05-09 2024-05-31 中山大学 母乳细胞外囊泡及其在制备骨修复材料中的应用
TWI872888B (zh) * 2022-12-30 2025-02-11 財團法人工業技術研究院 用於穩定血液中游離核酸及/或外泌體核酸的組成物、含其之試劑與套組以及其用途
CN116421738B (zh) * 2023-02-28 2024-03-19 中国医科大学附属第一医院 捕获抗原的溶瘤病毒及其药物组合与制备和应用
KR20240154736A (ko) * 2023-04-18 2024-10-28 가톨릭대학교 산학협력단 면역관문 억제제의 표적화된 전달을 위한 세포외소포체의 용도

Family Cites Families (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL154598B (nl) 1970-11-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
US3817837A (en) 1971-05-14 1974-06-18 Syva Corp Enzyme amplification assay
US3939350A (en) 1974-04-29 1976-02-17 Board Of Trustees Of The Leland Stanford Junior University Fluorescent immunoassay employing total reflection for activation
US3996345A (en) 1974-08-12 1976-12-07 Syva Company Fluorescence quenching with immunological pairs in immunoassays
US4275149A (en) 1978-11-24 1981-06-23 Syva Company Macromolecular environment control in specific receptor assays
US4277437A (en) 1978-04-05 1981-07-07 Syva Company Kit for carrying out chemically induced fluorescence immunoassay
US4366241A (en) 1980-08-07 1982-12-28 Syva Company Concentrating zone method in heterogeneous immunoassays
US4957939A (en) 1981-07-24 1990-09-18 Schering Aktiengesellschaft Sterile pharmaceutical compositions of gadolinium chelates useful enhancing NMR imaging
US4472509A (en) 1982-06-07 1984-09-18 Gansow Otto A Metal chelate conjugated monoclonal antibodies
US4938948A (en) 1985-10-07 1990-07-03 Cetus Corporation Method for imaging breast tumors using labeled monoclonal anti-human breast cancer antibodies
EP0573608A1 (en) 1991-02-07 1993-12-15 Molecumetics, Ltd. Conformationally restricted mimetics of beta turns and beta bulges and peptides containing the same
US5475085A (en) 1991-02-07 1995-12-12 Molecumetics, Ltd. Conformationally restricted mimetics of beta turns and beta bulges and peptides containing the same
GB9113120D0 (en) 1991-06-18 1991-08-07 Kodak Ltd Photographic processing apparatus
US5329028A (en) 1992-08-05 1994-07-12 Genentech, Inc. Carbohydrate-directed cross-linking reagents
KR950702839A (ko) 1992-08-27 1995-08-23 스티븐 딕 레트로, 인버소-, 및 레트로- 인버소 합성 펩티드 유사체(retro-, inverso-, and retro-inverso synthetic peptide analogues)
US5581476A (en) 1993-01-28 1996-12-03 Amgen Inc. Computer-based methods and articles of manufacture for preparing G-CSF analogs
US5446128A (en) 1993-06-18 1995-08-29 The Board Of Trustees Of The University Of Illinois Alpha-helix mimetics and methods relating thereto
AU6985594A (en) 1993-06-30 1995-01-24 Bonno Nammen Bouma Protein s deletion variants deficient in c4bp binding activity, but having apc cofactor activity, compositions and therapeutic methods
US5597457A (en) 1995-01-23 1997-01-28 The Regents Of The University Of California System and method for forming synthetic protein crystals to determine the conformational structure by crystallography
US5929237A (en) 1995-10-27 1999-07-27 Molecumetics Ltd. Reverse-turn mimetics and methods relating thereto
US5840833A (en) 1995-10-27 1998-11-24 Molecumetics, Ltd Alpha-helix mimetics and methods relating thereto
GB9526733D0 (en) 1995-12-30 1996-02-28 Delta Biotechnology Ltd Fusion proteins
WO1998029453A1 (en) 1996-12-27 1998-07-09 Mochida Pharmaceutical Co., Ltd. Cell membrane-directed drugs
US6093573A (en) 1997-06-20 2000-07-25 Xoma Three-dimensional structure of bactericidal/permeability-increasing protein (BPI)
BR9912053A (pt) 1998-07-13 2001-04-03 Univ Texas Processos de tratamento de câncer utilizando conjugados terapêuticos que se ligam a aminofosfolipìdios
WO2000009744A1 (en) 1998-08-13 2000-02-24 American Home Products Corporation Crystal structure of escherichia coli gdp-fucose synthetase and methods of its use
CA2340284A1 (en) 1998-08-25 2000-03-02 The Scripps Research Institute Methods and systems for predicting protein function
US6801860B1 (en) 1999-02-15 2004-10-05 Genetics Institute, Llc Crystal structure of cPLA2 and methods of identifying agonists and antagonists using same
US20040001827A1 (en) 2002-06-28 2004-01-01 Dennis Mark S. Serum albumin binding peptides for tumor targeting
JP2002003407A (ja) 2000-06-20 2002-01-09 Medei Sci Puraningu:Kk ハイドロキシアパタイトカルシウム指向性薬物輸送担体
EP1417628A4 (en) 2001-08-14 2007-01-31 Dana Farber Cancer Inst Inc COMPUTER-BASED METHODS FOR DESIGNING MOLECULES
US7807174B2 (en) 2002-11-22 2010-10-05 Nexbio, Inc. Class of therapeutic protein based molecules
JP4915918B2 (ja) 2003-06-19 2012-04-11 バイエル ヘルスケア エルエルシー 第VII因子または第VIIa因子のGlaドメイン変種
GB0315450D0 (en) 2003-07-01 2003-08-06 Celltech R&D Ltd Biological products
PT1644412E (pt) 2003-07-01 2015-12-23 Ucb Biopharma Sprl Fragmentos de anticorpos fab modificados
GB0315457D0 (en) 2003-07-01 2003-08-06 Celltech R&D Ltd Biological products
UA88272C2 (ru) * 2003-08-15 2009-10-12 Борд Оф Трастиз Оф Зе Юниверсити Оф Иллинойс Применение полипептидов семейства купредоксина в лечении рака
JP2007523099A (ja) 2004-02-20 2007-08-16 ノボ ノルディスク アクティーゼルスカブ 組み合わせ療法
GB0411186D0 (en) 2004-05-19 2004-06-23 Celltech R&D Ltd Biological products
ES2358204T3 (es) 2004-05-26 2011-05-06 Bayer Schering Pharma Aktiengesellschaft Adenovirus quiméricos para uso en el tratamiento del cáncer.
US7511016B2 (en) 2004-07-07 2009-03-31 Mosamedix B.V. Annexins, derivatives thereof, and annexin-cys variants, as well as therapeutic and diagnostic uses thereof
RU2396347C2 (ru) 2004-08-17 2010-08-10 Ксл Бехринг Гмбх Модифицированные витамин к-зависимые полипептиды
CA2591914C (en) 2005-01-24 2017-04-25 Board Of Regents, The University Of Texas System Fc-fusion constructs binding to phosphatidylserine and their therapeutic use
KR100987547B1 (ko) * 2006-06-01 2010-10-12 가톨릭대학교 산학협력단 냉동보관된 제대혈 줄기세포로부터 초기 세포사를 측정하는조성물, 키트 및 그 방법
JP5448840B2 (ja) 2006-12-22 2014-03-19 プシオクサス・セラピューティクス・リミテッド 腫瘍退縮アデノウイルスの作出およびその使用
JP5130580B2 (ja) * 2007-01-17 2013-01-30 独立行政法人放射線医学総合研究所 幹細胞における低線量被ばくの検出マーカー、及び該マーカーを用いる幹細胞での低線量被ばくレベルを推定又は検出する方法
RU2571931C2 (ru) 2007-04-13 2015-12-27 Каталист Биосайенсис, Инк. Полипептиды на основе модифицированного фактора vii и их применение
KR100968839B1 (ko) 2008-02-25 2010-07-09 경북대학교 산학협력단 포스파티딜세린과 특이적으로 결합하는 폴리펩티드 및 이의용도
TWI465247B (zh) * 2008-04-11 2014-12-21 Catalyst Biosciences Inc 經修飾的因子vii多肽和其用途
WO2010006136A2 (en) 2008-07-09 2010-01-14 Mayo Foundation For Medical Education And Research Adenovirus targeting
WO2010037402A1 (en) 2008-10-02 2010-04-08 Dako Denmark A/S Molecular vaccines for infectious disease
BRPI0920707A2 (pt) 2008-10-02 2015-12-29 Respivert Ltd compostos
US8283167B2 (en) 2009-02-11 2012-10-09 Clear Vascular Inc. Preparation of annexin derivatives
AU2010266065B2 (en) 2009-06-25 2016-01-14 The University Of North Carolina At Chapel Hill Chimeric Factor VII molecules
CA2787992A1 (en) * 2010-01-26 2011-08-04 Anthrogenesis Corporation Treatment of bone-related cancers using placental stem cells
US20140004601A1 (en) 2010-12-20 2014-01-02 Agency For Science, Technology And Research Method of purifying exosomes
EP2684045B2 (en) 2011-03-09 2023-03-29 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods to characterize patients suffering from hemolysis
ES2682750T5 (en) 2011-07-18 2025-02-04 Iba Lifesciences Gmbh Method of reversibly staining a target cell
WO2013151664A1 (en) 2012-04-02 2013-10-10 modeRNA Therapeutics Modified polynucleotides for the production of proteins
TWI497845B (zh) 2012-07-18 2015-08-21 Murata Manufacturing Co Coaxial connector
WO2014018535A1 (en) * 2012-07-25 2014-01-30 Salk Institute For Biological Studies Regulating the interaction between tam ligands and lipid membranes with exposed phosphatidylserine
AU2013200991B2 (en) 2012-09-19 2015-12-10 Georgetown University Targeted liposomes
PT3524618T (pt) * 2013-03-15 2023-06-06 Gladiator Biosciences Inc Domínios gla como agentes de marcação
PT3604333T (pt) * 2014-03-11 2021-06-07 Molecular Templates Inc Proteínas compreendendo regiões efetoras da subunidade a da toxina shiga próximas de amino-terminais e regiões de ligação do tipo imunoglobulina de direcionamento celular capazes de se ligarem especificamente a cd38
KR102496206B1 (ko) * 2014-06-11 2023-02-06 몰레큘러 템플레이츠, 인코퍼레이션. 프로테아제-절단 저항성의 시가 독소 a 서브유닛 작동체 폴리펩티드 및 이를 포함하는 세포-표적화 분자
CN105457032A (zh) * 2014-08-11 2016-04-06 中国人民解放军军事医学科学院毒物药物研究所 靶向癌干细胞的碳纳米管-盐霉素药物递送系统、其制备方法及用途
WO2017118764A1 (en) 2016-01-07 2017-07-13 Thomas Brocker Novel approaches for the in vivo and in vitro visualization of dying cells
CN105567642B (zh) * 2016-02-01 2019-07-12 中国科学院生物物理研究所 一种着色性干皮病人多能干细胞的制备方法
JP2020533976A (ja) 2017-09-05 2020-11-26 グラディエーター バイオサイエンシーズ インコーポレイテッド エキソソームを標的化する方法

Similar Documents

Publication Publication Date Title
Lombaert et al. Concise review: salivary gland regeneration: therapeutic approaches from stem cells to tissue organoids
Srinivasan et al. Primary salivary human stem/progenitor cells undergo microenvironment-driven acinar-like differentiation in hyaluronate hydrogel culture
Dissanayaka et al. In vitro analysis of scaffold-free prevascularized microtissue spheroids containing human dental pulp cells and endothelial cells
Lee et al. Spherical bullet formation via E-cadherin promotes therapeutic potency of mesenchymal stem cells derived from human umbilical cord blood for myocardial infarction
Dykstra et al. Concise review: fat and furious: harnessing the full potential of adipose-derived stromal vascular fraction
Lv et al. Concise review: the surface markers and identity of human mesenchymal stem cells
Brzoska et al. Sdf‐1 (CXCL12) improves skeletal muscle regeneration via the mobilisation of Cxcr4 and CD34 expressing cells
Paunescu et al. Tumour‐associated fibroblasts and mesenchymal stem cells: more similarities than differences
Winnier et al. Isolation of adipose tissue derived regenerative cells from human subcutaneous tissue with or without the use of an enzymatic reagent
Chen et al. Cellular kinetics of perivascular MSC precursors
JP2021080272A (ja) 改善された幹細胞組成物
Arno et al. Effect of human Wharton's jelly mesenchymal stem cell paracrine signaling on keloid fibroblasts
Hassan et al. Concise review: skeletal muscle stem cells and cardiac lineage: potential for heart repair
Lin et al. Small intestinal submucosa-derived extracellular matrix bioscaffold significantly enhances angiogenic factor secretion from human mesenchymal stromal cells
RU2013156357A (ru) Лечение дегенеративных изменений межпозвоночных дисков с использованием клеток, полученных из ткани пуповины человека
Wu et al. Exosomes from mesenchymal stem cells induce the conversion of hepatocytes into progenitor oval cells
Fierro et al. Hypoxic pre-conditioning increases the infiltration of endothelial cells into scaffolds for dermal regeneration pre-seeded with mesenchymal stem cells
Bae et al. The significance of SDF-1α-CXCR4 axis in in vivo angiogenic ability of human periodontal ligament stem cells
El-Haibi et al. Mesenchymal stem cells in the pathogenesis and therapy of breast cancer
Gomes et al. The impact of mesenchymal stem cells and their secretome as a treatment for gliomas
Zhou et al. Amniotic fluid-derived mesenchymal stem cells: characteristics and therapeutic applications
Costa et al. Dimethyloxalylglycine, a small molecule, synergistically increases the homing and angiogenic properties of human mesenchymal stromal cells when cultured as 3D spheroids
Allickson et al. Human adult stem cells from menstrual blood and endometrial tissue
CN106591372A (zh) 延缓人源骨髓间充质干细胞体外培养导致衰老的方法
Wang et al. Upregulation of Nanog and Sox‐2 genes following ectopic expression of Oct‐4 in amniotic fluid mesenchymal stem cells